Digital medicine and artificial intelligence: Semmelweis University set considerable goals to meet global standards
A strategic cooperation agreement on the development of digital therapies was signed by Semmelweis University, the Ministry of Innovation and Technology and Oncompass Medicine on Monday.
Dr József Bódis, Secretary of State for Higher Education, Innovation and Vocational Training emphasised that medical and health science institutions are internationally recognised elements of the Hungarian higher education system. The cooperation with Semmelweis University and Oncompass Medicine is considered crucial by the Ministry of Innovation in the strengthening of research and innovation activities and corporate relationships. The Ministry aims to support innovation in the Hungarian health industry, particularly in the fields of personalised diagnostics and therapy, digital health care and the medical application of artificial intelligence.
Photo: MTI/Koszticsák Szilárd
Dr Béla Merkely, Rector of Semmelweis University, said to Infostart that the institution has already demonstrated its ability to deliver world-class performance during the coronavirus crisis. Strategic cooperation facilitates research and development programs for the medical application of digital technologies and artificial intelligence.
Read alsoHungary’s first autonomous UV Disinfection Robot arrived at Semmelweis University
“By 2030, we [Semmelweis University] want to be among the top 100 universities in the world. This is a huge challenge which cannot be achieved without the international recognition of translational research activities,”
added Dr Merkely.
Oncompass Medicine Ltd. is a Hungarian healthcare and biotechnology company that develops innovative molecular diagnostic products and supports patients to find access to the best personalised and targeted cancer therapies. The company combines the methods of artificial intelligence and personalised medicine, which will presumably play a crucial role in the health care of the future. Through research and innovative developments, Oncompass aims to help oncologists to find the most appropriate cancer treatment strategy for their patients. The current cooperation provides opportunities for the company to develop innovative technologies and products that are competitive in the global market and could contribute to the development of digital health care.
The Ministry of Innovation and Technology is establishing science parks and knowledge parks in two locations in the capital city and six other rural locations. One of these developments is connected to Semmelweis University,
dr. Bódis said.
